Overview

About InSilicoMinds

InSilicoMinds specializes in providing AI and advanced modeling and simulation solutions for Pharma & Life Sciences. We leverage the best of breed validated global solutions and service providers to offer the best in class in silico solutions which help our clients optimize their drug development cycle, reduce costs, save time, and improve patient outcomes. InSilicoMinds enhances its portfolio of computational solutions through an exclusive partnership with InSilicoTrials, a premier provider of AI and simulation tools for drug development, reflecting both companies’ commitment to innovation and excellence in advancing drug research and development.

We are a team of experienced life sciences, digital innovation, and in silico experts that work together to provide our in silico solution. Our team has extensive experience working with a wide range of pharmaceutical and life sciences clients, from small startups to large multinational corporations. We understand the unique challenges facing these industries, and we have the knowledge and expertise to help our clients succeed.

Expertise

In Silico Modeling & Simulation
Bioinformatics & Computational Biology/Chemistry
Clinical Research & In Silico Trials
Domain Advisory & Consultancy
Staff Augmentation

No reviews submitted yet.
Be the first one to review

Focus

Service Focus of InSilicoMinds

How the team's effort is distributed across services.

30%25%25%10%10%

Industries Focus

100%

Client Focus

Small Business20%
Medium Business80%
Selected Work

Client Portfolio of InSilicoMinds

Where their work concentrates - by industry, budget, and timeline.

Clients: 2

Prediction Binding energies of drug moleculesIn silico QSTR Model

Where we are

Locations (1)

Offices where InSilicoMinds operates.

Headquarter
United States

United States

6658 Monterra Trl
San Diego, California 92130
8579983149

This profile is not fully claimed

Do you own or represent InSilicoMinds? Verify your business email to claim and manage this Goodfirms profile.